Por: The Boston Globe Nation November 03, 2022
The last remaining defendants in a once-sprawling opioid trial in New York settled Thursday, agreeing to pay over half a billion dollars for their role in fueling the opioid crisis, the state attorney general announced.The trial, which initially took on every facet of the supply chain that fed the deadly drug epidemic, began in September 2021 and lasted more than six months. One by one, the defendants settled until only Teva Pharmaceuticals, an... + full article
CNN USA Business November 03, 2022
New York CNN Business — The New York Attorney General’s office announced it has secured $523 million from Teva Pharmaceuticals and affiliates for its role in the opioid crisis, effectively marking the end of the state’s litigation against opioid manufacturers and... + más
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement | Forbes
Adderall Shortage Expected to Continue for Months in the U.S. | Time
Forbes USA Business November 03, 2022
Topline Teva Pharmaceuticals will shell out as much as much as $523 million in New York to settle claims that the company contributed to the opioid crisis that has killed nearly half a million Americans, part of a $4.2 billion national settlement for the company. April Mach, a... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis | CNN
WPLG Local 10 USA Health November 03, 2022
NEW YORK – New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic, the largest amount secured from an opioid manufacturer or distributor sued by the state, Attorney General Letitia James announced... + más
New York could get $524M under opioid settlements with Teva | ABC News
ABC News USA Health November 03, 2022
Teva Pharmaceuticals agreed Thursday to pay $523 million to settle claims stemming from the company’s role in the It’s the largest settlement New York has reached with an individual opioid defendant and raises the total amount secured from opioid manufacturers and... + más
NEW YORK -- New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic, the largest amount secured from an opioid manufacturer or distributor sued by the state, Attorney General Letitia James announced... + más
New York could get $524M under opioid settlements with Teva | WPLG Local 10
Time USA Health October 14, 2022
Teva Pharmaceutical Industries Ltd.’s shortage of Adderall is expected to last through March, longer than the two to three months the company , according to U.S. regulators. The popular treatment for attention-deficit/hyperactivity disorder has been in short supply since at... + más
Did COVID-19 pandemic contribute to Adderall shortage? | ABC News
Did COVID-19 pandemic contribute to Adderall shortage? | ABC7
Los Angeles Times USA Opinion September 24, 2022
Carvedilol could be the poster child for how to lower drug prices. Since 2007, over 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared with $4.81 for the brand-name product. Patents on... + más
Here's what Medicare recipients should know about Inflation Reduction Act | 10 WBNS
FDA warns against 'very unsafe' social media trends targeted at teenagers | ABC News
About iurex | Privacy Policy | Disclaimer |